|
Division Staff Locator
| Name |
Title/General Duties |
Phone |
Email |
Office of the Director
|
| Frank Vocci, Ph.D. |
Director |
301 443 6173 |
fv6k@nih.gov
|
| Richard "Dick" Hawks, Ph.D. |
Deputy Director |
301 443 2039 |
rhawks@nih.gov
|
| Jim Glass, M.S. |
Chief, Informatics Unit |
301 443 1112 |
jg96y@nih.gov
|
| Aida Klun, M.B.A. |
Program Analyst and Technology Transfer Coordinator |
301 443 1122 |
ak102w@nih.gov
|
Medical Consequences Branch
|
| Jag Khalsa, Ph.D. |
Chief |
301 443 2159 |
jk98p@nih.gov
|
| Jean Craft Comolli, R.N., M.B.A. |
Grants: Oro Maxillary Complications |
301 402 0630 |
jc282a@nih.gov
|
Clinical/Medical Branch
|
| Ahmed Elkashef, M.D. |
Chief |
301 443 5055 |
ae8a@nih.gov
|
| Roberta Kahn, M.D. |
Medical Safety Officer |
301 443 2281 |
rk185s@nih.gov
|
| Ann Anderson, MD. |
Medical Safety Officer |
301 435 0767 |
aa135m@nih.gov
|
| Shou Hua Li, Ph.D. |
Statistician |
301 443 9811 |
sli1@nida.nih.gov
|
| Barbara Herman, Ph.D |
CIT Program and Scientific Research |
301 443 9799 |
bh78q@nih.gov
|
| Liza Gorgon, M.A. |
Clinical Trials - Phase 2 and 3 and nicotine |
301 443 1138 |
lgorgon@nih.gov
|
| Jurij Mojsiak, M.S. |
Clinical Pharmacologist - Phase 1 |
301 443 9804 |
jm200p@nih.gov
|
| Erin Iturriaga, R.N., C.C.R.C. |
Clinical Trials - Phase 2 and 3 Methamphetamine and Marijuana |
301 443 1061 |
ei21g@nih.gov
|
| Edwina "Pat" Smith, R.N., M.S.N. |
Clincial Trials - Methamphetamine and Marijuana |
301 443 1061 |
es233s@nih.gov
|
| Donna Inman |
Clinical Trials - Budget |
301 443 1078 |
di13u@nih.gov
|
Regulatory Affairs Branch
|
| Robert "Bob" Walsh, B.S., R.A.C. |
Chief |
301 443 9825 |
rwalsh@nih.gov
|
| Marta De Santis, Ph.D. |
Regulatory Affairs Specialist |
301 443 0886 |
mdesantis@
nida.nih.gov
|
Chemistry and Pharmaceutics Branch
|
| Nora Chiang, Ph.D. |
Chief |
301 443 8099 |
nchiang@nih.gov
|
| Richard "Rik" Kline, Ph.D. |
Medicinal Chemist |
301 443 8293 |
rik@nih.gov
|
| Moo Park, Ph.D. |
Chemist – Biopharmaceutics, Pharmaceutics, and Pharmacokinetics |
301 443 9813 |
mp264a@nih.gov
|
| Ming Shih, Ph.D. |
Chemist - Medicinal/Analytical |
301 443 8422 |
mshih@mail.nih.gov
|
| Amrat Patel, Ph.D. |
Pharmacologist - Drug Metabolism and Pharmacokinetics |
301 443 8476 |
ap79g@nih.gov
|
| Charles Marschke, B.S. |
Chemist: Management Discovery Compound Rresources |
301 443 8211 |
cm109u@nih.gov
|
Medications Discovery and Toxicology Branch
|
| David McCann, Ph.D. |
Chief |
301 443 2999 |
dmccann@nih.gov
|
| Jane B. Acri, Ph.D. |
Pharmacologist |
301 443 8489 |
ja96v@nih.gov
|
| Naresh Chand, D.V.M., Ph.D. |
Cardiotoxicologist |
301 443 8895 |
nc114a@nih.gov
|
| Nathan M. Appel, Ph.D. |
Neurotoxicologist |
301 443 8475 |
nappel@nih.gov
|
| Hirsch Davis, M.A. |
Psychologist |
301 443 8849 |
hdavis@nida.nih.gov
|
| Carol Hubner, Ph.D. |
Pharmacologist |
301 443 4459 |
ch83a@nih.gov
|
| David White, Ph.D. |
Pharmacologist |
301 443 8889 |
whitedav@nida.nih.gov
|
Medications Research Grants Branch
|
| Jamie Biswas, Ph.D. |
Chief, Immunotherapy; Adolescent Drug Abuse; Substance Abuse Treatment in the Criminal Justice System: Cocaine |
301 443 8096 |
jb168r@nih.gov
|
| Ivan Montoya, M.D., M.P.H. |
Marijuana, Nicotine, Opiates |
301 443 8639 |
imontoya@nih.gov
|
| Steve Oversby, R.N., Psy.D. |
MOTHER grants, Methamphetamine, Cocaine, Opiates |
301 435 0762 |
soversby@mail.nih.gov
|
|
|
DPMCDA Index
About NIDA Contents
|
|
